Article

CVD May Increase Risk of Cognitive Decline in Older Women

The results of a recent study identified a relationship between cardiovascular disease and cognitive decline in postmenopausal women.

A relationship between cardiovascular disease (CVD) and cognitive decline in postmenopausal women was identified in a recent study published online in the Journal of the American Heart Association. In women without CVD, hypertension and diabetes increased the risk for cognitive decline. No significant relationship was found between atrial fibrillation and heart failure with cognitive functioning.

To read the full article at HCPLive.com, click here.

Related Videos
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Related Content
Atlanta, GA, USA - June 15, 2022: Closeup of the CDC logo seen at the Edward R. Roybal campus, the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
June 2nd 2025

CDC Clarifies That Kids May Receive COVID-19 Vaccine Through Shared Clinical Decision-Making

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
FDA Approves mRNA-1283 COVID-19 Vaccine for Adults 65 and Older, Those With Underlying Conditions
June 2nd 2025

FDA Approves mRNA-1283 COVID-19 Vaccine for Adults 65 and Older, Those With Underlying Conditions

Luke Halpern, Assistant Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction
June 2nd 2025

NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction

Steven E. Nissen, MD, MACC Alana Hippensteele, Lead Editor
Drawing of the gut microbiome | Image Credit: © ArtemisDiana - stock.adobe.com
May 31st 2025

From Resistance to Response: The Microbiome’s Role in Optimizing Cancer Therapy

Alexandra Gerlach, Associate Editor